These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21475661)

  • 21. Capitalizing on commercialization: should congress revisit the Bayh-Dole Act?
    Bruckbauer S
    J Natl Cancer Inst; 2003 Oct; 95(19):1429-31. PubMed ID: 14519745
    [No Abstract]   [Full Text] [Related]  

  • 22. Deep Brain Stimulation, Free Markets and the Scientific Commons: Is It time to Revisit the Bayh-Dole Act of 1980?
    Fins JJ
    Neuromodulation; 2010 Jul; 13(3):153-9. PubMed ID: 21992826
    [No Abstract]   [Full Text] [Related]  

  • 23. Bayh-Dole: if we knew then what we know now.
    Boettiger S; Bennett AB
    Nat Biotechnol; 2006 Mar; 24(3):320-3. PubMed ID: 16525405
    [No Abstract]   [Full Text] [Related]  

  • 24. Legal, ethical, and conceptual bottlenecks to the development of useful genomic tests.
    Tomasson M
    Ann Health Law; 2009; 18(2):231-60, 8 p. preceding i. PubMed ID: 21950240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Private and public values of innovation: A patent analysis of synthetic biology.
    Ribeiro B; Shapira P
    Res Policy; 2020 Feb; 49(1):103875. PubMed ID: 32015589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intellectual property. University licensing and the Bayh-Dole Act.
    Thursby JG; Thursby MC
    Science; 2003 Aug; 301(5636):1052. PubMed ID: 12933996
    [No Abstract]   [Full Text] [Related]  

  • 27. The demise of Bayh-Dole protections against the Pharmaceutical Industry's abuses of government-funded inventions.
    Schofield AR
    J Law Med Ethics; 2004; 32(4):777-83. PubMed ID: 15807367
    [No Abstract]   [Full Text] [Related]  

  • 28. Protecting essential information about genetic variants as trade secrets: a problem for public policy?
    Juergens AK; Francis LP
    J Law Biosci; 2018 Dec; 5(3):682-705. PubMed ID: 31143458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. March-in rights under the Bayh-Dole Act: the NIH's paper tiger?
    O'Brien W
    Seton Hall Law Rev; 2013 Nov; 43(4):1403-32. PubMed ID: 24308083
    [No Abstract]   [Full Text] [Related]  

  • 30. Technology transfer at US universities: seeking public benefit from the results of basic research.
    Goodwin CD
    Technol Health Care; 1996 Sep; 4(3):323-30. PubMed ID: 8931243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Confronting conflict: addressing institutional conflicts of interest in academic medical centers.
    Liang BA; Mackey T
    Am J Law Med; 2010; 36(1):136-87. PubMed ID: 20481404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Bayh-Dole Coalition responds.
    Allen JP
    Nature; 2023 May; 617(7960):252. PubMed ID: 37161010
    [No Abstract]   [Full Text] [Related]  

  • 33. Can we expect to achieve anything from Indian Bayh Dole?
    Janodia MD; Sreedhar D; Ligade VS; Udupa N
    Indian J Med Res; 2009 Oct; 130(4):487. PubMed ID: 19942757
    [No Abstract]   [Full Text] [Related]  

  • 34. Global biotech expansion taking cues from Bayh-Dole.
    Howard K
    Nat Biotechnol; 2004 Jul; 22(7):919-20. PubMed ID: 15259190
    [No Abstract]   [Full Text] [Related]  

  • 35. Who owns federally funded research? The Supreme court and the Bayh-Dole act.
    Kesselheim AS; Rajkumar R
    N Engl J Med; 2011 Sep; 365(13):1167-9. PubMed ID: 21879888
    [No Abstract]   [Full Text] [Related]  

  • 36. University-based science and biotechnology products: defining the boundaries of intellectual property.
    Kesselheim AS; Avorn J
    JAMA; 2005 Feb; 293(7):850-4. PubMed ID: 15713775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lessons from Bayh-Dole.
    Sampat BN
    Nature; 2010 Dec; 468(7325):755-6. PubMed ID: 21150971
    [No Abstract]   [Full Text] [Related]  

  • 38. Conflict of interest dilemmas in biomedical research.
    Witt MD; Gostin LO
    JAMA; 1994 Feb; 271(7):547-51. PubMed ID: 8301771
    [No Abstract]   [Full Text] [Related]  

  • 39. Is Bayh-Dole good for developing countries? Lessons from the US experience.
    So AD; Sampat BN; Rai AK; Cook-Deegan R; Reichman JH; Weissman R; Kapczynski A
    PLoS Biol; 2008 Oct; 6(10):e262. PubMed ID: 18959484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Managing financial conflicts of interest in clinical research.
    Cohen JJ
    Sci Eng Ethics; 2002 Jul; 8(3):401-6. PubMed ID: 12353369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.